UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000011682 |
|---|---|
| Receipt number | R000013637 |
| Scientific Title | Phase 2 study of Gemcitabine, Dexamethasone, and Cisplatin (GDP) therapy for refractory/relapsed malignant lymphoma. |
| Date of disclosure of the study information | 2013/09/09 |
| Last modified on | 2019/01/28 10:58:17 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/09/09 07:08:29 | ||
| 2 | Update | 2019/01/28 10:58:17 | Recruitment status Publication of results |
